Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 16:35:12 18/09/2024 BST			5-day change	1st Jan Change
1,604.00 ^GBX	-0.34%		-4.01%	+10.61%

06:13pm	European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August	MT
05:05pm	GSK Settles Two California Lawsuits Related to Zantac	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	88,051	66,801	80,458	58,381	59,112	65,427	-	-
Change	-	-24.13%	20.44%	-27.44%	1.25%	10.68%	-	-
Enterprise Value (EV) ¹	113,773	87,581	100,296	75,578	74,152	77,342	73,977	69,905
Change	-	-23.02%	14.52%	-24.65%	-1.89%	4.3%	-4.35%	-5.5%
P/E ratio	19.2x	11.8x	18.6x	3.93x	11.9x	12.9x	10.4x	9.32x
PBR	7.35x	4.58x	5.34x	5.47x	4.4x	4.14x	3.4x	2.8x
PEG	-	0.5x	-0.8x	0x	-0.2x	5.05x	0.4x	0.8x
Capitalization / Revenue	2.61x	1.96x	2.36x	1.99x	1.95x	2.07x	1.96x	1.85x
EV / Revenue	3.37x	2.57x	2.94x	2.58x	2.45x	2.44x	2.22x	1.97x
EV / EBITDA	9.51x	9.19x	8.85x	7.23x	6.37x	7.25x	6.33x	5.49x
EV / EBIT	12.7x	9.83x	11.4x	9.27x	8.44x	8.39x	7.34x	6.24x
EV / FCF	22.4x	16.2x	22.6x	12.1x	13.6x	14.8x	11x	9.52x
FCF Yield	4.46%	6.17%	4.42%	8.28%	7.36%	6.77%	9.08%	10.5%
Dividend per Share ²	1	1	1	0.6125	0.58	0.6032	0.6411	0.6807
Rate of return	4.5%	5.96%	4.98%	4.26%	4%	3.76%	4%	4.24%
EPS ²	1.158	1.426	1.082	3.662	1.216	1.247	1.542	1.721
Distribution rate	86.4%	70.1%	92.4%	16.7%	47.7%	48.4%	41.6%	39.6%
Net sales ¹	33,754	34,099	34,114	29,324	30,328	31,639	33,391	35,399
EBITDA ¹	11,968	9,530	11,330	10,449	11,635	10,671	11,685	12,744
EBIT ¹	8,972	8,906	8,806	8,151	8,786	9,222	10,081	11,195
Net income ¹	4,645	5,749	4,385	14,956	4,928	5,016	6,368	7,081
Net Debt ¹	25,722	20,780	19,838	17,197	15,040	11,915	8,550	4,479
Reference price ²	22.24	16.78	20.08	14.38	14.50	16.04	16.04	16.04
Nbr of stocks (in thousands)	3,959,572	3,982,185	4,006,383	4,060,999	4,076,145	4,078,961	-	-
Announcement Date	05/02/20	03/02/21	09/02/22	01/02/23	31/01/24	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
GSK PLC	12.62x	2.45x	7.27x	+3.75%	86.44B
ELI LILLY AND COMPANY	58.43x	18.1x	44.03x	+0.57%	816B
NOVO NORDISK A/S	39.78x	13.85x	28.21x	+1.26%	597B
JOHNSON & JOHNSON	21.39x	4.63x	13.08x	+2.80%	402B
ABBVIE INC.	37.65x	7.14x	15.41x	+3.22%	342B
MERCK & CO., INC.	15.77x	5.01x	11.47x	+2.60%	300B
ROCHE HOLDING AG	15.97x	3.78x	9.76x	+3.70%	253B
ASTRAZENECA PLC	28.23x	5.08x	15.2x	+1.97%	244B
NOVARTIS AG	21.48x	4.95x	12.53x	+3.27%	234B
AMGEN INC.	51.27x	6.9x	12.08x	+2.76%	179B
Average	30.26x	7.19x	16.90x	+2.59%	345.33B
Weighted average by Cap.	35.86x	9.74x	22.77x	+2.09%